Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab

J. A. Vargo; B. M. Snelling; E. R. Ghareeb; K. John; J. N. Frame; J. N. Frame; J. H. Schmidt; K. B. Peters

doi:10.1007/S11060-010-0519-8

Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab

J. A. Vargo
, B. M. Snelling
, E. R. Ghareeb
, K. John
, J. N. Frame
, J. N. Frame
, J. H. Schmidt
, K. B. Peters

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	104
DOIs	https://doi.org/10.1007/S11060-010-0519-8
State	Published - Jan 8 2011

Disciplines

Medicine and Health Sciences
Radiology
Surgery

Access to Document

10.1007/S11060-010-0519-8License: Unspecified

Cite this

@article{7197685e4bb74d67bd5d95382e2d8f4b,

title = "Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab",

author = "Vargo, \{J. A.\} and Snelling, \{B. M.\} and Ghareeb, \{E. R.\} and K. John and Frame, \{J. N.\} and Frame, \{J. N.\} and Schmidt, \{J. H.\} and Peters, \{K. B.\}",

note = "Malignant gliomas have long been a therapeutic dilemma in neuro-oncology, with a poor overall prognosis. Standard treatment, consisting of primary resection, followed by radiation therapy and temozolomide, has improved prognosis. Recently, studies have looked at the addition of bevacizumab (Avastin) ...",

year = "2011",

month = jan,

day = "8",

doi = "10.1007/S11060-010-0519-8",

language = "American English",

volume = "104",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab

AU - Vargo, J. A.

AU - Snelling, B. M.

AU - Ghareeb, E. R.

AU - John, K.

AU - Frame, J. N.

AU - Schmidt, J. H.

AU - Peters, K. B.

N1 - Malignant gliomas have long been a therapeutic dilemma in neuro-oncology, with a poor overall prognosis. Standard treatment, consisting of primary resection, followed by radiation therapy and temozolomide, has improved prognosis. Recently, studies have looked at the addition of bevacizumab (Avastin) ...

PY - 2011/1/8

Y1 - 2011/1/8

UR - http://www.ncbi.nlm.nih.gov/pubmed/21221711

U2 - 10.1007/S11060-010-0519-8

DO - 10.1007/S11060-010-0519-8

M3 - Article

VL - 104

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab

Disciplines

Access to Document

Other files and links

Cite this